Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03793361
Title Phase II Study of Regorafenib as Maintenance Therapy
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Centre Oscar Lambret
Indications
Therapies
Age Groups: adult | senior
Covered Countries FRA

Facility Status City State Zip Country Details
CHRU Besançon Besançon 25000 France Details
Institut Bergonié Bordeaux 33076 France Details
Centre François Baclesse Caen 14076 France Details
Centre Georges-François LECLERC Dijon 21079 France Details
Centre Oscar Lambret Lille 59020 France Details
Centre Léon Bérard Lyon 69373 France Details
Hôpital La Timone Marseille 13005 France Details
Institut Paoli-Calmettes Marseille 13273 France Details
Institut régional du Cancer de Montpellier Montpellier 34298 France Details
Centre René Gauducheau Nantes 44805 France Details
Centre Antoine Lacassagne Nice 06189 France Details
Institut Curie Paris 75005 France Details
Chu Poitiers Poitiers 86000 France Details
Institut Godinot Reims 51100 France Details
Centre Eugène Marquis Rennes 35042 France Details
Centre Henri Becquerel Rouen 76038 France Details
Institut de Cancérologie Lucien Neuwirth Saint-Priest-en-Jarez 42270 France Details
Hôpitaux universitaires de Strasbourg Strasbourg 67000 France Details
Institut Claudius Regaud Toulouse 31059 France Details
Institut Gustave Roussy Villejuif 94805 France Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field